Sleeping sickness and the brain

被引:42
作者
Enanga, B [1 ]
Burchmore, RJS [1 ]
Stewart, ML [1 ]
Barrett, MP [1 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
关键词
sleeping sickness; central nervous system; blood brain barrier; trypanosome; chemotherapy;
D O I
10.1007/s00018-002-8472-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent progress in understanding the neuropathological mechanisms of sleeping sickness reveals a complex relationship between the trypanosome parasite that causes this disease and the host nervous system. The pathology of late-stage sleeping sickness, in which the central nervous system is involved, is complicated and is associated with disturbances in the circadian rhythm of sleep. The blood-brain barrier, which separates circulating blood from the central nervous system, regulates the flow of materials to and from the brain. During the course of disease, the integrity of the blood-brain barrier is compromised. Dysfunction of the nervous system may be exacerbated by factors of trypanosomal origin or by host responses to parasites. Microscopic examination of cerebrospinal fluid remains the best way to confirm late-stage sleeping sickness, but this necessitates a risky lumbar puncture. Most drugs, including many trypanocides, do not cross the blood-brain barrier efficiently. Improved diagnostic and therapeutic approaches are thus urgently required. The latter might benefit from approaches which manipulate the blood-brain barrier to enhance permeability or to limit drug efflux. This review summarizes our current understanding of the neurological aspects of sleeping sickness, and envisages new research into blood-brain barrier models that are necessary to understand the interactions between trypanosomes and drugs active against them within the host nervous system.
引用
收藏
页码:845 / 858
页数:14
相关论文
共 137 条
[91]   EFLORNITHINE CONCENTRATIONS IN SERUM AND CEREBROSPINAL-FLUID OF 63 PATIENTS TREATED FOR TRYPANOSOMA-BRUCEI-GAMBIENSE SLEEPING SICKNESS [J].
MILORD, F ;
LOKO, L ;
ETHIER, L ;
MPIA, B ;
PEPIN, J .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1993, 87 (04) :473-477
[92]  
MONCADA S, 1985, PHARMACOL BASIS THER, P660
[93]   Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model [J].
Mulenga, C ;
Mhlanga, JDM ;
Kristensson, K ;
Robertson, B .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2001, 27 (01) :77-85
[94]   Relative contribution of interferon-γ and interleukin-10 to resistance to murine African trypanosomosis [J].
Namangala, B ;
Noël, W ;
De Baetselier, P ;
Brys, L ;
Beschin, A .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (12) :1794-1800
[95]  
Nichols AC, 2000, J PARASITOL, V86, P177, DOI 10.1645/0022-3395(2000)086[0177:ACAOPW]2.0.CO
[96]  
2
[97]   CORRELATION OF HIGH SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA WITH DISEASE SEVERITY IN HUMAN AFRICAN TRYPANOSOMIASIS [J].
OKOMOASSOUMOU, MC ;
DAULOUEDE, S ;
LEMESRE, JL ;
NZILAMOUANDA, A ;
VINCENDEAU, P .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 53 (05) :539-543
[98]   CIRCULATING ANTIBODIES DIRECTED AGAINST TRYPTOPHAN-LIKE EPITOPES IN SERA OF PATIENTS WITH HUMAN AFRICAN TRYPANOSOMIASIS [J].
OKOMOASSOUMOU, MC ;
GEFFARD, M ;
DAULOUEDE, S ;
CHAUGIER, C ;
LEMESRE, JL ;
VINCENDEAU, P .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (05) :461-467
[99]   BIDIRECTIONAL ACTIVATING SIGNALS BETWEEN TRYPANOSOMA-BRUCEI AND CD8+ T-CELLS - A TRYPANOSOME-RELEASED FACTOR TRIGGERS INTERFERON-GAMMA PRODUCTION THAT STIMULATES PARASITE GROWTH [J].
OLSSON, T ;
BAKHIET, M ;
EDLUND, C ;
HOJEBERG, B ;
VANDERMEIDE, PH ;
KRISTENSSON, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (10) :2447-2454
[100]   LEUKOCYTE ADHESION TO ENDOTHELIUM IN INFLAMMATION [J].
OSBORN, L .
CELL, 1990, 62 (01) :3-6